Psylo 4001
Alternative Names: Psylo-4001Latest Information Update: 29 Apr 2024
Price :
$50 *
At a glance
- Originator Psylo
- Class Antidepressants; Neuropsychotherapeutics
- Mechanism of Action Serotonin 5-HT2A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders; Major depressive disorder
Most Recent Events
- 29 Apr 2024 Preclinical trials in Depressive disorders in Australia (unspecified route) prior to April 2024 (Psylo pipeline, April 2024)
- 29 Apr 2024 Preclinical trials in Major depressive disorder in Australia (unspecified route) prior to April 2024 (Psylo pipeline, April 2024)
- 13 Jul 2023 Early research in Depressive disorders in Australia (unspecified route) (Psylo pipeline, July 2023)